abstract |
The invention relates to bicyclo [3.3.0] octane derivatives substituted in position 9 of formula (I), and their salts with physiologically acceptable bases, as well as alpha-, beta- or gamma-cyclodextrin-clathrates and compounds of formula (I) encapsulated with liposomes, their manufacturing process and their pharmaceutical application. |